ArbidolHCl CAS:131707-23-8

Arbidol HCl has demonstrated efficacy in the treatment and prophylaxis of influenza and other respiratory viral infections. As a therapeutic agent, it is used for managing symptoms and reducing the duration of illness caused by influenza viruses. Additionally, Arbidol HCl is employed as a prophylactic measure to reduce the risk of viral respiratory infections, especially during flu seasons or in high-risk populations. Its ability to inhibit viral entry and replication makes it a valuable tool in controlling outbreaks and managing the spread of influenza and other respiratory viruses. Furthermore, ongoing research indicates potential applications of Arbidol HCl in combating emerging viral diseases and addressing public health challenges posed by novel viruses. Overall, Arbidol HCl plays a crucial role in antiviral therapy and public health strategies aimed at mitigating the impact of influenza and other viral respiratory infections.